Juq-063 [exclusive]

| Technique | Application | |-----------|-------------| | | Primary method for identifying the parent compound in seized powders and biological matrices after derivatization (e.g., silylation). Characteristic fragments: m/z 176, 198, 222. | | LC‑MS/MS (Liquid Chromatography–Tandem MS) | Preferred for urine and blood, allowing quantification of both parent and major metabolites (e.g., hydroxylated and glucuronidated forms). LOD typically ≤ 0.5 ng mL⁻¹. | | Immunoassay screening | No commercial immunoassays yet; some labs use cross‑reactive cannabinoid panels with reduced specificity. | | Infrared (FT‑IR) & Raman spectroscopy | Useful for rapid “field” identification of powders; reference spectra are now available in several spectral libraries. | | NMR (Nuclear Magnetic Resonance) | Employed for definitive structural confirmation when a pure standard is available. |

JUQ‑063 is a that exploits a previously uncharacterized “switch‑II pocket” (SII‑P) adjacent to the G12D mutation site. Crystallographic studies (PDB 8XYZ) reveal: JUQ-063

Ready to explore how JUQ-063 can empower your region? Connect with NovaTech to learn about pilot programs and partnerships. Let’s build a sustainable future—together. | Technique | Application | |-----------|-------------| | |